Literature DB >> 15228160

Doping control from a global and national perspective.

Albert D Fraser1.   

Abstract

The practice of enhancing athletic performance through foreign substances was known from the earliest Olympic games. In 1967, the International Olympic Committee (IOC) established a Medical Commission responsible for developing a list of prohibited substances and methods. Drug tests were first introduced at the Olympic winter games in Grenoble and at the summer games in Mexico City in 1968. In February 1999, the IOC convened the World Conference on Doping in Sport in Lausanne, Switzerland. The Lausanne Declaration on Doping in Sport recommended creation of an International Anti-Doping Agency. The World Anti-Doping Agency (WADA) was formed in Lausanne, Switzerland on the basis of equal representation from the Olympic movement and public authorities. One of the mandates of WADA was to harmonize the Olympic antidoping code and develop a single code applicable and acceptable for all stakeholders. The world antidoping code developed by WADA included creation of several international standards (IS). The purpose of each IS was harmonization among antidoping organizations. The ISs were developed for laboratories, testing, the prohibited list, and for therapeutic use exemptions (TUE). The objective of this manuscript is to present a brief history of doping in sport and describe creation of WADA in 1999. The components of the World Anti-Doping code (in particular, the Therapeutic Use Exclusion program or TUE) is described. The WADA code defines a TUE as "permission to use, for therapeutic purposes, a drug or drugs which are otherwise prohibited in sporting competition." Experiences of the Canadian Centre for Ethics in Sport Doping Control Review Board are presented because this national TUE committee has been operational for over 12 years. The challenge of developing a rigorous global antidoping program requires acceptance of doping as a problem by sport organizations, athletes, and public authorities. Individual stakeholders must be prepared to preserve the values of sport, which means free from doping. This will require vigilance by all interested parties for the benefit of elite athletes and society overall.

Mesh:

Substances:

Year:  2004        PMID: 15228160     DOI: 10.1097/00007691-200404000-00015

Source DB:  PubMed          Journal:  Ther Drug Monit        ISSN: 0163-4356            Impact factor:   3.681


  8 in total

1.  Doping awareness, views, and experience: a comparison between general practitioners and pharmacists.

Authors:  Irena Auersperger; Mojca Doupona Topič; Petra Maver; Vika Kuferšin Pušnik; Joško Osredkar; Mitja Lainščak
Journal:  Wien Klin Wochenschr       Date:  2011-10-28       Impact factor: 1.704

Review 2.  [Interdisciplinary strategies versus doping].

Authors:  Karin Vitzthum; Stefanie Mache; David Quarcoo; David A Groneberg; Norman Schöffel
Journal:  Wien Klin Wochenschr       Date:  2010-06       Impact factor: 1.704

3.  Drug consumption during the 2004 Olympics: the special Olympic Pharmacy.

Authors:  Maria Skouroliakou; Chara Kani; Steven Kompogiorgas; Vassilis Kontozamanis
Journal:  Pharm World Sci       Date:  2005-12

4.  Doping and the Olympic games: the good, the bad, and the ugly.

Authors:  Mitja Lainscak; Josko Osredkar
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

5.  Potentially harmful advantage to athletes: a putative connection between UGT2B17 gene deletion polymorphism and renal disorders with prolonged use of anabolic androgenic steroids.

Authors:  Nawed Deshmukh; Andrea Petróczi; James Barker; Andrea D Székely; Iltaf Hussain; Declan P Naughton
Journal:  Subst Abuse Treat Prev Policy       Date:  2010-04-29

Review 6.  "Boosting" in Paralympic athletes with spinal cord injury: doping without drugs.

Authors:  Filomena Mazzeo; Stefania Santamaria; Alessandro Iavarone
Journal:  Funct Neurol       Date:  2015 Apr-Jun

Review 7.  Seasonal allergy and seasonal decrements in athletic performance.

Authors:  Hirsh D Komarow; Teodor T Postolache
Journal:  Clin Sports Med       Date:  2005-04       Impact factor: 2.182

Review 8.  The Role of Nationality in Ultra-Endurance Sports: The Paradigm of Cross-Country Skiing and Long-Distance Running.

Authors:  Beat Knechtle; Thomas Rosemann; Pantelis Theo Nikolaidis
Journal:  Int J Environ Res Public Health       Date:  2020-04-08       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.